Acute Sterol O-Acyltransferase 2 (SOAT2) Knockdown Rapidly Mobilizes Hepatic Cholesterol for Fecal Excretion

• Stephanie M. Marshall,

  Affiliation Department of Pathology, Section on Lipid Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America

  ⨯
• Anthony D. Gromovsky,

  Affiliation Department of Cellular and Molecular Medicine, Cleveland Clinic Foundation – Lerner Research Institute, Cleveland, Ohio, United States of America

  ⨯
• Kathryn L. Kelley,

  Affiliation Department of Pathology, Section on Lipid Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America

  ⨯
• Matthew A. Davis,

  Affiliation Department of Pathology, Section on Lipid Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America

  ⨯
• Martha D. Wilson,

  Affiliation Department of Pathology, Section on Lipid Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America

  ⨯
• Richard G. Lee,

  Affiliation Cardiovascular Group, Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, United States of America

  ⨯
• Rosanne M. Crooke,

  Affiliation Cardiovascular Group, Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, United States of America

  ⨯
• Mark J. Graham,

  Affiliation Cardiovascular Group, Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, United States of America

  ⨯
• Lawrence L. Rudel,

  Affiliation Department of Pathology, Section on Lipid Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America

  ⨯
• J. Mark Brown ,

  Contributed equally to this work with: J. Mark Brown, Ryan E. Temel

  * E-mail: brownm5@ccf.org (JMB); ryan.temel@uky.edu (RET)

  Affiliations Department of Pathology, Section on Lipid Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America, Department of Cellular and Molecular Medicine, Cleveland Clinic Foundation – Lerner Research Institute, Cleveland, Ohio, United States of America

  ⨯
• Ryan E. Temel

  Contributed equally to this work with: J. Mark Brown, Ryan E. Temel

  * E-mail: brownm5@ccf.org (JMB); ryan.temel@uky.edu (RET)

  Affiliations Department of Pathology, Section on Lipid Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America, Saha Cardiovascular Research Center, University of Kentucky, Lexington, Kentucky, United States of America

  ⨯